Chemotherapy for Uterine (Endometrial) Cancer
En Español (Spanish Version)

Cancer chemotherapy is the use of drugs to kill cancer cells. Unlike radiation and surgery, which are localized treatments, chemotherapy is a systemic treatment, meaning the drugs travel throughout the whole body. This means chemotherapy can reach cancer cells that may have spread (metastasized) to other areas.

Chemotherapy is not commonly used for endometrial cancer. The treatment may be ordered for Stage IV disease, when the cancer has spread to other parts of the body, or if the disease recurs. The drugs are often given in combination and in cycles. All of these drugs are given intravenously at the doctor’s office or in the hospital.

Chemotherapy Drugs Used for Uterine Cancer:
  • Cisplatin
  • Cyclophosphamide (Cytoxan)
  • Doxorubicin (Adriamycin)
  • Carboplatin
  • Paclitaxel
  • Ifosfamide
Combination chemotherapy regimens used in uterine cancer include:
  • CAP (Cyclophosphamide, Adriamycin, Cisplatin)
  • Cisplatin and doxorubicin
  • Cyclophosphamide and doxorubicin
  • Carboplatin and Paclitaxel

Effectiveness
Doctors have yet to find a chemotherapy regimen that is curative or highly effective for advanced or recurrent uterine cancer. In various studies, the response rates to chemotherapy range from 36% to 67%. However, even in patients who respond to treatment, the response lasts only four to eight months on average.

Chemotherapy is sometimes combined with hormonal therapy for the treatment of advanced or recurrent uterine cancer.




References:
Abeloff M. Clinical Oncology. 2nd ed. Orlando, FL: Churchill Livingstone, Inc; 2000: 1987-2008.

American Cancer Society website. Available at: http://www.cancer.org/ .

Bast R, Kufe D, Pollock R, et al, eds. Cancer Medicine. 5th ed. Hamilton, Ontario: BC Decker Inc; 2000.

National Cancer Institute website. Available at: http://www.nci.nih.gov/ .

Rakel R. Bope E, ed. Conn's Current Therapy. 54th ed. St. Louis, MO: WB Saunders; 2002: 1094-1096.

Last Reviewed December 2013



Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

 

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

 

To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.